Searched for: Department/Unit:Child and Adolescent Psychiatry
Mental Health Among Children Older than 10Â Years Exposed to the Haiti 2010 Earthquake: a Critical Review
Blanc, Judite; Eugene, Dominique; Louis, Elizabeth Farrah; Cadichon, Jeff Matherson; Joseph, Jolette; Pierre, Anderson; Laine, Roudly; Alexandre, Margarett; Huang, Keng-Yen
PURPOSE OF REVIEW/OBJECTIVE:There is evidence that the exposure to a major natural disaster such as the 2010 earthquake in Haiti may have devastating short- and long-term effects on children's mental health and overall development. This review summarizes what has been reported in the past 3Â years (2017-2020) regarding emotional, psychological, and behavioral effects of exposure to this particular earthquake on children 10Â years and older. RECENT FINDINGS/RESULTS:Twenty-six articles were screened, of which twenty-one were selected for final analysis. The main themes addressed in the literature over the 3Â years concerned prevalence of post-traumatic stress disorder (PTSD), depression, determinants of resilience factors, prevalence of sexual violence as well as prenatal exposure, and subsequent autism behaviors/symptoms. The majority of the findings analyzed in this review on mental health in young Haitian survivors of the 2010 earthquake came from cross-sectional studies conducted in West region of Haiti, spefically Port-au-Prince. There was a paucity of longitudinal and translational data available. The results of this critical review can be used to inform disaster preparedness programs with the aim of protecting children's development and mental health, which are much needed on this disaster-prone island.
PMID: 32876808
ISSN: 1535-1645
CID: 4603282
Early Life Stress and the Development of the Infant Gut Microbiota: Implications for Mental Health and Neurocognitive Development
Vogel, Sarah C; Brito, Natalie H; Callaghan, Bridget L
PURPOSE OF REVIEW/OBJECTIVE:We review the state of the literature examining associations between early life stress (ELS), gut microbiota, and neurocognitive development and mental health in animals and humans. We identify gaps in current models and areas for future research. RECENT FINDINGS/RESULTS:ELS is associated with changes in gut microbiota, which correspond to changes in affective and cognitive functioning in both animals and humans. Some of these ELS-induced psychological changes can be remedied by supplementation with probiotics in early life, suggesting a potential area for intervention for ELS-exposed children. Prenatal stress exposure is rarely studied in humans in relation to gut microbiota, but animal work has suggested important associations between prenatal stress and fetal programming that should be tested in humans. The gut microbiota plays an important role in the association between ELS, neurocognitive development, and mental health. More work is needed to fully understand these associations in humans.
PMID: 32918633
ISSN: 1535-1645
CID: 4603442
Endocrine Insights into the Pathophysiology of Autism Spectrum Disorder
Wilson, Hayley A; Creighton, Carolyn; Scharfman, Helen; Choleris, Elena; MacLusky, Neil J
Autism spectrum disorder (ASD) is a class of neurodevelopmental disorders that affects males more frequently than females. Numerous genetic and environmental risk factors have been suggested to contribute to the development of ASD. However, no one factor can adequately explain either the frequency of the disorder or the male bias in its prevalence. Gonadal, thyroid, and glucocorticoid hormones all contribute to normal development of the brain, hence perturbations in either their patterns of secretion or their actions may constitute risk factors for ASD. Environmental factors may contribute to ASD etiology by influencing the development of neuroendocrine and neuroimmune systems during early life. Emerging evidence suggests that the placenta may be particularly important as a mediator of the actions of environmental and endocrine risk factors on the developing brain, with the male being particularly sensitive to these effects. Understanding how various risk factors integrate to influence neural development may facilitate a clearer understanding of the etiology of ASD.
PMID: 32912048
ISSN: 1089-4098
CID: 4598212
Increasing Access for the Treatment of Eating Disorders Among College Students
Shatkin, Jess P
PMID: 32865569
ISSN: 2574-3805
CID: 4593902
A Marshall Plan for Children's Mental Health After COVID-19
Hoagwood, Kimberly Eaton; Kelleher, Kelly J
PMID: 32933414
ISSN: 1557-9700
CID: 4592982
Locus coeruleus: a new look at the blue spot
Poe, Gina R; Foote, Stephen; Eschenko, Oxana; Johansen, Joshua P; Bouret, Sebastien; Aston-Jones, Gary; Harley, Carolyn W; Manahan-Vaughan, Denise; Weinshenker, David; Valentino, Rita; Berridge, Craig; Chandler, Daniel J; Waterhouse, Barry; Sara, Susan J
The locus coeruleus (LC), or 'blue spot', is a small nucleus located deep in the brainstem that provides the far-reaching noradrenergic neurotransmitter system of the brain. This phylogenetically conserved nucleus has proved relatively intractable to full characterization, despite more than 60 years of concerted efforts by investigators. Recently, an array of powerful new neuroscience tools have provided unprecedented access to this elusive nucleus, revealing new levels of organization and function. We are currently at the threshold of major discoveries regarding how this tiny brainstem structure exerts such varied and significant influences over brain function and behaviour. All LC neurons receive inputs related to autonomic arousal, but distinct subpopulations of those neurons can encode specific cognitive processes, presumably through more specific inputs from the forebrain areas. This ability, combined with specific patterns of innervation of target areas and heterogeneity in receptor distributions, suggests that activation of the LC has more specific influences on target networks than had initially been imagined.
PMID: 32943779
ISSN: 1471-0048
CID: 4593442
Testing an individualized digital decision assist system for the diagnosis and management of mental and behavior disorders in children and adolescents
Clausen, Carolyn E; Leventhal, Bennett L; Nytrø, Øystein; Koposov, Roman; Westbye, Odd Sverre; Røst, Thomas Brox; Bakken, Victoria; Koochakpour, Kaban; Thorvik, Ketil; Skokauskas, Norbert
BACKGROUND:Nearly half of all mental health disorders develop prior to the age of 15. Early assessments, diagnosis, and treatment are critical to shortening single episodes of care, reducing possible comorbidity and long-term disability. In Norway, approximately 20% of all children and adolescents are experiencing mental health problems. To address this, health officials in Norway have called for the integration of innovative approaches. A clinical decision support system (CDSS) is an innovative, computer-based program that provides health professionals with clinical decision support as they care for patients. CDSS use standardized clinical guidelines and big data to provide guidance and recommendations to clinicians in real-time. IDDEAS (Individualised Digital DEcision Assist System) is a CDSS for diagnosis and treatment of child and adolescent mental health disorders. The aim of IDDEAS is to enhance quality, competency, and efficiency in child and adolescent mental health services (CAMHS). METHODS/DESIGN/METHODS:IDDEAS is a mixed-methods innovation and research project, which consists of four stages: 1) Assessment of Needs and Preparation of IDDEAS; 2) The Development of IDDEAS CDSS Model; 3) The Evaluation of the IDDEAS CDSS; and, 4) Implementation & Dissemination. Both qualitative and quantitative methods will be used for the evaluation of IDDEAS CDSS model. Child and adolescent psychologists and psychiatrists (n = 30) will evaluate the IDDEAS` usability, acceptability and relevance for diagnosis and treatment of attention-deficit/hyperactivity disorder. DISCUSSION/CONCLUSIONS:The IDDEAS CDSS model is the first guidelines and data-driven CDSS to improve efficiency of diagnosis and treatment of child and adolescent mental health disorders in Norway. Ultimately, IDDEAS will help to improve patient health outcomes and prevent long-term adverse outcomes by providing each patient with evidence-based, customized clinical care. TRIAL REGISTRATION/BACKGROUND:ISRCTN, ISRCTN12094788. Ongoing study, registered prospectively 8 April 2020 https://doi.org/10.1186/ISRCTN12094788.
PMID: 32943029
ISSN: 1472-6947
CID: 4593402
Pharmacologic Treatment of Attention Deficit-Hyperactivity Disorder
Cortese, Samuele
PMID: 32905677
ISSN: 1533-4406
CID: 4589232
Familial coaggregation of major psychiatric disorders in first-degree relatives of individuals with autism spectrum disorder: a nationwide population-based study
Wang, Hohui E; Cheng, Chih-Ming; Bai, Ya-Mei; Hsu, Ju-Wei; Huang, Kai-Lin; Su, Tung-Ping; Tsai, Shih-Jen; Li, Cheng-Ta; Chen, Tzeng-Ji; Leventhal, Bennett L; Chen, Mu-Hong
BACKGROUND:Family coaggregation of attention-deficit/hyperactivity disorder (ADHD), autism spectrum disorder (ASD), bipolar disorder (BD), major depressive disorder (MDD) and schizophrenia have been presented in previous studies. The shared genetic and environmental factors among psychiatric disorders remain elusive. METHODS:This nationwide population-based study examined familial coaggregation of major psychiatric disorders in first-degree relatives (FDRs) of individuals with ASD. Taiwan's National Health Insurance Research Database was used to identify 26 667 individuals with ASD and 67 998 FDRs of individuals with ASD. The cohort was matched in 1:4 ratio to 271 992 controls. The relative risks (RRs) and 95% confidence intervals (CI) of ADHD, ASD, BD, MDD and schizophrenia were assessed among FDRs of individuals with ASD and ASD with intellectual disability (ASD-ID). RESULTS:FDRs of individuals with ASD have higher RRs of major psychiatric disorders compared with controls: ASD 17.46 (CI 15.50-19.67), ADHD 3.94 (CI 3.72-4.17), schizophrenia 3.05 (CI 2.74-3.40), BD 2.22 (CI 1.98-2.48) and MDD 1.88 (CI 1.76-2.00). Higher RRs of schizophrenia (4.47, CI 3.95-5.06) and ASD (18.54, CI 16.18-21.23) were observed in FDRs of individuals with both ASD-ID, compared with ASD only. CONCLUSIONS:The risk for major psychiatric disorders was consistently elevated across all types of FDRs of individuals with ASD. FDRs of individuals with ASD-ID are at further higher risk for ASD and schizophrenia. Our results provide leads for future investigation of shared etiologic pathways of ASD, ID and major psychiatric disorders and highlight the importance of mental health care delivered to at-risk families for early diagnoses and interventions.
PMID: 32914742
ISSN: 1469-8978
CID: 4589582
Feasibility, Acceptability, and Effectiveness of a New Cognitive-Behavioral Intervention for College Students with ADHD
Solanto, Mary V; Scheres, Anouk
OBJECTIVE:This purpose of this study was to assess the feasibility, acceptability, and effectiveness of a new group cognitive-behavioral treatment (CBT) to enhance executive function (EF) in college students with ADHD. METHODS:Eighteen students meeting rigorous DSM-5 criteria for ADHD were enrolled in two nine-member groups. The treatment targeted time-awareness, distractibility, procrastination, and failure to plan, and included strategies to facilitate academic EF skills. RESULTS:Eighty-four percent of students attended nine or more of the 12 weekly sessions. Repeated measures analyses of change from pre- to posttreatment yielded improvement in clinician- and self-ratings of DSM-5 ADHD inattentive symptoms, with robust effect sizes. Also improved were scores on standardized scales of time-management, concentration, and total EF. DISCUSSION/CONCLUSIONS:Results provide support for the feasibility, acceptability, and effectiveness of a CBT program in reducing inattentive symptoms and enhancing EF in college students with ADHD, and warrant investigation on a larger scale.
PMID: 32880502
ISSN: 1557-1246
CID: 4588402